semaglutide digestive blockage lawsuit in west virginia gastrointestinal obstruction class action Semaglutide-based medications such as Ozempic and Wegovy louisiana semaglutide digestive blockage law

The semaglutide group lost an average of 14.9% of their body weight, compared with 2.4% for the placebo group

GCG agonism increases energy expenditure through enhanced lipolysis, hepatic fatty acid oxidation, and stimulating thermogenesis, while improving hepatic lipid metabolism, collectively contributing to weight loss (Fig

(3) Results: six RCTs, with 4744 participants, were included in the final analysis

Springer International Publishing, 463482

Along with causing people to lose face, the treatment has also been blamed for sagging glutes, dubbed "Ozempic butt," vision problems, bowel obstruction, foul belches, gastrointestinal distress, stomach paralysis and even personality changes